199 related articles for article (PubMed ID: 24915177)
1. A comparison of protein kinases inhibitor screening methods using both enzymatic activity and binding affinity determination.
Rudolf AF; Skovgaard T; Knapp S; Jensen LJ; Berthelsen J
PLoS One; 2014; 9(6):e98800. PubMed ID: 24915177
[TBL] [Abstract][Full Text] [Related]
2. Use of Protein Kinase-Focused Compound Libraries for the Discovery of New Inositol Phosphate Kinase Inhibitors.
Puhl-Rubio AC; Stashko MA; Wang H; Hardy PB; Tyagi V; Li B; Wang X; Kireev D; Jessen HJ; Frye SV; Shears SB; Pearce KH
SLAS Discov; 2018 Oct; 23(9):982-988. PubMed ID: 29842835
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors paradoxically prime kinases.
Frye SV; Johnson GL
Nat Chem Biol; 2009 Jul; 5(7):448-9. PubMed ID: 19465930
[No Abstract] [Full Text] [Related]
4. Fluorescence labels in kinases: a high-throughput kinase binding assay for the identification of DFG-out binding ligands.
Simard JR; Rauh D
Methods Mol Biol; 2012; 800():95-117. PubMed ID: 21964785
[TBL] [Abstract][Full Text] [Related]
5. Determination of Affinity and Residence Time of Potent Drug-Target Complexes by Label-free Biosensing.
Quinn JG; Pitts KE; Steffek M; Mulvihill MM
J Med Chem; 2018 Jun; 61(12):5154-5161. PubMed ID: 29772180
[TBL] [Abstract][Full Text] [Related]
6. Global kinase screening. Applications of frontal affinity chromatography coupled to mass spectrometry in drug discovery.
Slon-Usakiewicz JJ; Dai JR; Ng W; Foster JE; Deretey E; Toledo-Sherman L; Redden PR; Pasternak A; Reid N
Anal Chem; 2005 Mar; 77(5):1268-74. PubMed ID: 15732906
[TBL] [Abstract][Full Text] [Related]
7. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
[TBL] [Abstract][Full Text] [Related]
8. Systematic Profiling and Evaluation of Structure-based Kinase-Inhibitor Interactome in Cervical Cancer by Integrating In Silico Analyses and In Vitro Assays at Molecular and Cellular Levels.
Zhu LX; Liu Q; Hua YF; Yang N; Zhang XG; Ding X
Comput Biol Chem; 2019 Jun; 80():324-332. PubMed ID: 31078911
[TBL] [Abstract][Full Text] [Related]
9. Small molecules that allosterically inhibit p21-activated kinase activity by binding to the regulatory p21-binding domain.
Kim DJ; Choi CK; Lee CS; Park MH; Tian X; Kim ND; Lee KI; Choi JK; Ahn JH; Shin EY; Shin I; Kim EG
Exp Mol Med; 2016 Apr; 48(4):e229. PubMed ID: 27126178
[TBL] [Abstract][Full Text] [Related]
10. An improved zinc cocktail-mediated fluorescence polarization-based kinase assay for high-throughput screening of kinase inhibitors.
Chopra P; Nanda K; Chatterjee M; Bajpai M; Dastidar SG; Ray A
Anal Biochem; 2008 Sep; 380(1):143-5. PubMed ID: 18570885
[TBL] [Abstract][Full Text] [Related]
11. Virtual target screening: validation using kinase inhibitors.
Santiago DN; Pevzner Y; Durand AA; Tran M; Scheerer RR; Daniel K; Sung SS; Woodcock HL; Guida WC; Brooks WH
J Chem Inf Model; 2012 Aug; 52(8):2192-203. PubMed ID: 22747098
[TBL] [Abstract][Full Text] [Related]
12. Doing more than just the structure-structural genomics in kinase drug discovery.
Marsden BD; Knapp S
Curr Opin Chem Biol; 2008 Feb; 12(1):40-5. PubMed ID: 18267130
[TBL] [Abstract][Full Text] [Related]
13. A small molecule discrimination map of the antibiotic resistance kinome.
Shakya T; Stogios PJ; Waglechner N; Evdokimova E; Ejim L; Blanchard JE; McArthur AG; Savchenko A; Wright GD
Chem Biol; 2011 Dec; 18(12):1591-601. PubMed ID: 22195561
[TBL] [Abstract][Full Text] [Related]
14. A robust and quantitative assay platform for multiplexed, high throughput screening of protein kinase inhibitors.
Lee J; Park IS; Park G; Cho K; Park HS; Min DH
Chem Commun (Camb); 2016 Oct; 52(81):12112-12115. PubMed ID: 27709210
[TBL] [Abstract][Full Text] [Related]
15. FLiK: a direct-binding assay for the identification and kinetic characterization of stabilizers of inactive kinase conformations.
Simard JR; Rauh D
Methods Enzymol; 2014; 548():147-71. PubMed ID: 25399645
[TBL] [Abstract][Full Text] [Related]
16. The design, annotation, and application of a kinase-targeted library.
Xi H; Lunney EA
Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomics of kinase inhibitor targets and mechanisms.
Daub H
ACS Chem Biol; 2015 Jan; 10(1):201-12. PubMed ID: 25474541
[TBL] [Abstract][Full Text] [Related]
18. Drug discovery and the human kinome: recent trends.
Eglen R; Reisine T
Pharmacol Ther; 2011 May; 130(2):144-56. PubMed ID: 21256157
[TBL] [Abstract][Full Text] [Related]
19. Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview.
Fischer PM
Med Res Rev; 2017 Mar; 37(2):314-367. PubMed ID: 27775829
[TBL] [Abstract][Full Text] [Related]
20. An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase.
Deacon SW; Beeser A; Fukui JA; Rennefahrt UE; Myers C; Chernoff J; Peterson JR
Chem Biol; 2008 Apr; 15(4):322-31. PubMed ID: 18420139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
